https://stock.noler.com/us/stock/meridian-bioscience-inc https://stock.noler.com/us/stock/meridian-bioscience-inc/accounts-payable https://stock.noler.com/us/stock/meridian-bioscience-inc/accrual-carrying-value-current https://stock.noler.com/us/stock/meridian-bioscience-inc/accrual-carrying-value-payments https://stock.noler.com/us/stock/meridian-bioscience-inc/accrual-payments https://stock.noler.com/us/stock/meridian-bioscience-inc/accrual-provision https://stock.noler.com/us/stock/meridian-bioscience-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/meridian-bioscience-inc/accrued-income-taxes-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/accrued-liabilities-current https://stock.noler.com/us/stock/meridian-bioscience-inc/accumulated-depreciation https://stock.noler.com/us/stock/meridian-bioscience-inc/accumulated-oci-foreign-currency-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/acquired-inventory https://stock.noler.com/us/stock/meridian-bioscience-inc/acquired-property-plant-and-equipment https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/meridian-bioscience-inc/acquisitions https://stock.noler.com/us/stock/meridian-bioscience-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/meridian-bioscience-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/meridian-bioscience-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/meridian-bioscience-inc/additions-to-noncurrent-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/meridian-bioscience-inc/amended-reports-10-k https://stock.noler.com/us/stock/meridian-bioscience-inc/amended-reports-10-k405 https://stock.noler.com/us/stock/meridian-bioscience-inc/amended-reports-10-q https://stock.noler.com/us/stock/meridian-bioscience-inc/amortization https://stock.noler.com/us/stock/meridian-bioscience-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/aoci https://stock.noler.com/us/stock/meridian-bioscience-inc/assets-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/basic-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/buildings-and-improvements-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-pro-forma-net-income-loss https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-pro-forma-revenue https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-purchase-price-allocation-current-assets-cash-and-cash-equivalents https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-purchase-price-allocation-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-purchase-price-allocation-current-assets-receivables https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-purchase-price-allocation-goodwill-expected-tax-deductible-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisition-purchase-price-allocation-tangible-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/meridian-bioscience-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/meridian-bioscience-inc/capital-expenditures https://stock.noler.com/us/stock/meridian-bioscience-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/meridian-bioscience-inc/cash https://stock.noler.com/us/stock/meridian-bioscience-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/meridian-bioscience-inc/cash-and-equivalents https://stock.noler.com/us/stock/meridian-bioscience-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/meridian-bioscience-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/meridian-bioscience-inc/cash-flow-breakdown https://stock.noler.com/us/stock/meridian-bioscience-inc/clinical-trials https://stock.noler.com/us/stock/meridian-bioscience-inc/common-dividends-paid https://stock.noler.com/us/stock/meridian-bioscience-inc/common-stock-dividends-per-share-cash-paid https://stock.noler.com/us/stock/meridian-bioscience-inc/common-stock-no-par-value https://stock.noler.com/us/stock/meridian-bioscience-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/meridian-bioscience-inc/common-stock-value https://stock.noler.com/us/stock/meridian-bioscience-inc/compensating-balance-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/comprehensive-income https://stock.noler.com/us/stock/meridian-bioscience-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/meridian-bioscience-inc/construction-in-progress-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/cost-of-goods-sold https://stock.noler.com/us/stock/meridian-bioscience-inc/cost-of-revenue https://stock.noler.com/us/stock/meridian-bioscience-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/meridian-bioscience-inc/cumulative-effect-of-initial-adoption-of-fin-48 https://stock.noler.com/us/stock/meridian-bioscience-inc/current-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/current-liabilities https://stock.noler.com/us/stock/meridian-bioscience-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/meridian-bioscience-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/meridian-bioscience-inc/debt-issued https://stock.noler.com/us/stock/meridian-bioscience-inc/debt-repaid https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-income-tax-assets-net https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-other-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-equity-method-investments https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/meridian-bioscience-inc/deferred-tax-liability-not-recognized-cumulative-amount-of-temporary-difference https://stock.noler.com/us/stock/meridian-bioscience-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/meridian-bioscience-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/meridian-bioscience-inc/depreciation https://stock.noler.com/us/stock/meridian-bioscience-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-assets-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-gain-loss-recognized-in-income-ineffective-portion-net https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-instruments-gain-recognized-in-income https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-notional-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-number-of-instruments-held https://stock.noler.com/us/stock/meridian-bioscience-inc/derivative-swaption-interest-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/diluted-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/dilutive-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/meridian-bioscience-inc/dividends-declared https://stock.noler.com/us/stock/meridian-bioscience-inc/dividends-paid https://stock.noler.com/us/stock/meridian-bioscience-inc/dividends-per-share https://stock.noler.com/us/stock/meridian-bioscience-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/meridian-bioscience-inc/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/meridian-bioscience-inc/effective-tax-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/meridian-bioscience-inc/eps https://stock.noler.com/us/stock/meridian-bioscience-inc/eps-basic https://stock.noler.com/us/stock/meridian-bioscience-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/meridian-bioscience-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/meridian-bioscience-inc/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/financing-cash-flow https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/meridian-bioscience-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/foreign-currency-transaction-gain-loss-realized https://stock.noler.com/us/stock/meridian-bioscience-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/meridian-bioscience-inc/foreign-earnings https://stock.noler.com/us/stock/meridian-bioscience-inc/foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/foreign-pretax-income https://stock.noler.com/us/stock/meridian-bioscience-inc/future-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/meridian-bioscience-inc/future-amortization-expense-year-five https://stock.noler.com/us/stock/meridian-bioscience-inc/future-amortization-expense-year-four https://stock.noler.com/us/stock/meridian-bioscience-inc/future-amortization-expense-year-one https://stock.noler.com/us/stock/meridian-bioscience-inc/future-amortization-expense-year-three https://stock.noler.com/us/stock/meridian-bioscience-inc/future-amortization-expense-year-two https://stock.noler.com/us/stock/meridian-bioscience-inc/gain-loss-on-contract-termination https://stock.noler.com/us/stock/meridian-bioscience-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/gain-loss-on-disposition-of-assets-1 https://stock.noler.com/us/stock/meridian-bioscience-inc/gain-loss-on-foreign-currency-non-hedging-derivatives https://stock.noler.com/us/stock/meridian-bioscience-inc/general-and-administrative-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/goodwill https://stock.noler.com/us/stock/meridian-bioscience-inc/goodwill-change https://stock.noler.com/us/stock/meridian-bioscience-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/meridian-bioscience-inc/gross-profit https://stock.noler.com/us/stock/meridian-bioscience-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/meridian-bioscience-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/meridian-bioscience-inc/income-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/meridian-bioscience-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/income-taxes-paid https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-operating-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-operating-liabilities https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/meridian-bioscience-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/meridian-bioscience-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/meridian-bioscience-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/meridian-bioscience-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/meridian-bioscience-inc/interest-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/interest-paid https://stock.noler.com/us/stock/meridian-bioscience-inc/interest-paid-net https://stock.noler.com/us/stock/meridian-bioscience-inc/interest-payable-current https://stock.noler.com/us/stock/meridian-bioscience-inc/interest-rate-cash-flow-hedge-asset-at-fair-value https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-adjustments https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-raw-materials https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-work-in-process https://stock.noler.com/us/stock/meridian-bioscience-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/meridian-bioscience-inc/investing-cash-flow https://stock.noler.com/us/stock/meridian-bioscience-inc/investment-income-interest https://stock.noler.com/us/stock/meridian-bioscience-inc/investment-income-interest-and-dividend https://stock.noler.com/us/stock/meridian-bioscience-inc/land https://stock.noler.com/us/stock/meridian-bioscience-inc/legal-fees https://stock.noler.com/us/stock/meridian-bioscience-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/meridian-bioscience-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/liabilities-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/line-of-credit https://stock.noler.com/us/stock/meridian-bioscience-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/meridian-bioscience-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/meridian-bioscience-inc/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/meridian-bioscience-inc/litigation-reserve-current https://stock.noler.com/us/stock/meridian-bioscience-inc/long-term-debt https://stock.noler.com/us/stock/meridian-bioscience-inc/loss-in-period https://stock.noler.com/us/stock/meridian-bioscience-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/meridian-bioscience-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/meridian-bioscience-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/meridian-bioscience-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/meridian-bioscience-inc/net-change-in-cash https://stock.noler.com/us/stock/meridian-bioscience-inc/net-income https://stock.noler.com/us/stock/meridian-bioscience-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-adoption-quantification https://stock.noler.com/us/stock/meridian-bioscience-inc/notional-amount-of-cash-flow-hedge-instruments https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-available-for-sale-adjustment-before-tax-change https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-before-tax-change https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-cash-flow-hedge-gain-loss-after-reclassification-and-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-cash-flow-hedge-gain-loss-after-reclassification-and-tax-parent https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-cash-flow-hedge-gain-loss-reclassification-after-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-derivatives-qualifying-as-hedges-before-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-derivatives-qualifying-as-hedges-before-tax-change https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-derivatives-qualifying-as-hedges-net-of-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-transaction-and-translation-adjustment-before-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-transaction-and-translation-adjustment-before-tax-2 https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-transaction-and-translation-adjustment-before-tax-change https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-translation-adjustment-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-foreign-currency-translation-adjustment-tax-2 https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-net-of-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-net-of-tax-2 https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-net-of-tax-change https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-tax-1 https://stock.noler.com/us/stock/meridian-bioscience-inc/oci-unrealized-holding-gain-loss-on-securities-arising-before-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-cash-flow https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-expenses https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-income https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-liability https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-liability-current https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/meridian-bioscience-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/meridian-bioscience-inc/other-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/other-income https://stock.noler.com/us/stock/meridian-bioscience-inc/other-noncurrent-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/meridian-bioscience-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/paid-in-capital-income-tax-deficiency-from-share-based-compensation https://stock.noler.com/us/stock/meridian-bioscience-inc/paid-in-capital-share-based-compensation-and-exercise-of-stock-options https://stock.noler.com/us/stock/meridian-bioscience-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/meridian-bioscience-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/meridian-bioscience-inc/patents-pending https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-for-proceeds-from-previous-acquisition https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-for-restructuring https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-of-financing-costs https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-of-merger-related-costs-financing-activities https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/meridian-bioscience-inc/pension-and-other-postretirement-defined-benefit-plans-liabilities-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/preferred-shares-facts https://stock.noler.com/us/stock/meridian-bioscience-inc/preferred-stock-no-par-value https://stock.noler.com/us/stock/meridian-bioscience-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/meridian-bioscience-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/meridian-bioscience-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/meridian-bioscience-inc/preferred-stock-value https://stock.noler.com/us/stock/meridian-bioscience-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/meridian-bioscience-inc/prepaid-expense-current https://stock.noler.com/us/stock/meridian-bioscience-inc/pretax-income https://stock.noler.com/us/stock/meridian-bioscience-inc/pretax-income-domestic https://stock.noler.com/us/stock/meridian-bioscience-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-long-term-lines-of-credit https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-sale-of-buildings https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-sale-of-short-term-investments https://stock.noler.com/us/stock/meridian-bioscience-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/meridian-bioscience-inc/profit-loss https://stock.noler.com/us/stock/meridian-bioscience-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/property-plant-equipment https://stock.noler.com/us/stock/meridian-bioscience-inc/public-float https://stock.noler.com/us/stock/meridian-bioscience-inc/purchase-obligations-balance-on-first-anniversary https://stock.noler.com/us/stock/meridian-bioscience-inc/purchase-obligations-balance-on-second-anniversary https://stock.noler.com/us/stock/meridian-bioscience-inc/purchase-obligations-balance-on-third-anniversary https://stock.noler.com/us/stock/meridian-bioscience-inc/purchase-obligations-due-after-five-years https://stock.noler.com/us/stock/meridian-bioscience-inc/receivables-net-current https://stock.noler.com/us/stock/meridian-bioscience-inc/related-parties-amount-in-cost-of-sales https://stock.noler.com/us/stock/meridian-bioscience-inc/repayments-of-lines-of-credit https://stock.noler.com/us/stock/meridian-bioscience-inc/reporting-unit-percentage-of-fair-value-in-excess-of-carrying-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/research-and-development https://stock.noler.com/us/stock/meridian-bioscience-inc/restricted-cash https://stock.noler.com/us/stock/meridian-bioscience-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/restricted-cash-and-investments-noncurrent https://stock.noler.com/us/stock/meridian-bioscience-inc/restructuring-charges https://stock.noler.com/us/stock/meridian-bioscience-inc/restructuring-reserve https://stock.noler.com/us/stock/meridian-bioscience-inc/restructuring-reserve-accrual-adjustment https://stock.noler.com/us/stock/meridian-bioscience-inc/retained-earnings https://stock.noler.com/us/stock/meridian-bioscience-inc/revenue https://stock.noler.com/us/stock/meridian-bioscience-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/meridian-bioscience-inc/revenues-from-transactions-with-other-operating-segments-of-same-entity https://stock.noler.com/us/stock/meridian-bioscience-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/meridian-bioscience-inc/royalty-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/royalty-income-nonoperating https://stock.noler.com/us/stock/meridian-bioscience-inc/sales-commissions-and-fees https://stock.noler.com/us/stock/meridian-bioscience-inc/sales-revenue-net https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-comment-letters-sec-staff-letter https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-10-k https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-10-q https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-11-k https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-15-12g https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-25-nse https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-8-k https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-ars https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-def-14a https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-defa14a https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-defm14a https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-prem14a https://stock.noler.com/us/stock/meridian-bioscience-inc/sec-filings-sd https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/meridian-bioscience-inc/secondary-offerings-form-t-3 https://stock.noler.com/us/stock/meridian-bioscience-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/shareholders-equity https://stock.noler.com/us/stock/meridian-bioscience-inc/shares-authorized https://stock.noler.com/us/stock/meridian-bioscience-inc/shares-issued https://stock.noler.com/us/stock/meridian-bioscience-inc/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-fair-value-assumptions-expected-term-maximum https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-fair-value-assumptions-expected-term-minimum https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-maximum-employee-subscription-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-award-plan-modification-number-of-employees-affected https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-based-compensation https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-compensation-tax-benefit-realized-from-exercise-of-stock-options https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-issued-shares-issued-value-conversion-of-units https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-exercisable-remaining-term https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-nonvested-number-of-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-nonvested-options-forfeited-grant-date-fair-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-nonvested-options-forfeited-number-of-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-outstanding-remaining-term https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/meridian-bioscience-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-cuts-and-jobs-act-change-in-tax-rate-income-tax-expense-benefit https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-deductions-dividends https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-rate-reconciliation-tax-cuts-and-jobs-act-transition-tax-on-accumulated-foreign-earnings-amount https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-deductions-dividends https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-nondeductible-expense-amortization https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-nondeductible-expense-depreciation https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-nondeductible-expense-impairment-losses https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-repatriation-of-foreign-earnings https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/meridian-bioscience-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/meridian-bioscience-inc/taxes-payable-current https://stock.noler.com/us/stock/meridian-bioscience-inc/total-assets https://stock.noler.com/us/stock/meridian-bioscience-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/meridian-bioscience-inc/trading-securities-debt-current https://stock.noler.com/us/stock/meridian-bioscience-inc/treasury-stock-shares https://stock.noler.com/us/stock/meridian-bioscience-inc/treasury-stock-value https://stock.noler.com/us/stock/meridian-bioscience-inc/unrealized-gain-loss-on-securities https://stock.noler.com/us/stock/meridian-bioscience-inc/unrecognized-deferred-tax-liability https://stock.noler.com/us/stock/meridian-bioscience-inc/unrecognized-deferred-tax-liability-foreign-earnings https://stock.noler.com/us/stock/meridian-bioscience-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-change https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/meridian-bioscience-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/meridian-bioscience-inc/valuation-allowance-deferred-tax-asset-change-in-amount